A once-daily GLP-1 pill helped Japanese adults lose weight in a large trial
☕ Includes a question for the family ↓
GLP-1 drugs (Ozempic, Wegovy, Mounjaro)Part of a story we are following · 4 articles · See every update
If the idea of a weekly shot has kept you from looking into weight-loss medicine, here is news worth a second cup of coffee. Researchers tested a GLP-1 drug that comes as a pill you swallow once a day, and it worked.
The pill is called orforglipron. Most GLP-1 drugs, the medicines that help you feel full sooner, are injections. In this trial, adults who took the pill lost a meaningful share of their body weight, while those on a placebo barely changed.
How the study worked
This was a phase 3 trial, the large final stage of testing. It ran at 16 medical centers in Japan and included 238 adults who had obesity-related health problems such as high blood pressure, high cholesterol or type 2 diabetes, and who had already tried dieting without lasting success. They were assigned by chance to a daily pill at 6 mg, 12 mg or 36 mg, or to a placebo, and neither they nor the researchers knew who got what. The trial lasted 72 weeks, and 90% of participants finished it. It was published on Oct. 30, 2026, in The Lancet Diabetes & Endocrinology, and it was funded by the drug’s maker, Eli Lilly, with Japanese adults only.
What they found
People on the pill lost clearly more weight than people on the placebo, at every dose. The placebo group barely changed.
The study also counted how many people lost at least 5% of their body weight, a milestone doctors treat as meaningful for health. Far more people on the pill reached it than people on the placebo.
Side effects were mostly mild to moderate stomach symptoms, the kind other GLP-1 drugs are known for. Nausea was the most common reason people stopped the pill. It happened in 5 of 60 people at the highest dose, and in 1 of 61 at the lowest dose and 1 of 57 at the middle dose. No one on the placebo stopped for that reason.
Why does a pill matter?
GLP-1 is a hormone your gut makes after you eat. It slows digestion and tells your brain you are full. Many GLP-1 drugs are proteins, and proteins are broken down in the stomach, which is why they have to be injected.
Orforglipron is not a protein. It is a small molecule, so it can be swallowed. It does not need special rules like taking it on an empty stomach. A pill is also easier to make, store and ship than an injection. That is a good sign for people who want more choices in how they take this kind of medicine.
What you can do today
Get ready for that conversation now. Open the notes app on your phone and write down every medicine and supplement you take, plus your health conditions, such as blood pressure or blood sugar. Bring the list to your next doctor or pharmacist visit and ask what weight-loss options are available to you today.
Talk about it at home
Your stomach and brain talk to each other with tiny chemical messages. After a meal, your gut sends one that says, “I’m full.” Scientists found a way to copy that message in a medicine, first as a shot, and now as a pill you can swallow.
Question for the table
Here is a question to chew on at the table: if you wanted to know whether a medicine really works, why would one group get a pill that looks the same but has nothing in it?
Keep exploring
Copies this article and its questions so you can paste them into ChatGPT, Claude, Gemini or the AI you use, and keep the conversation going.
Questions and answers
- What is orforglipron?
- A GLP-1 drug that is not a protein, so it can be taken as a pill once a day instead of an injection.
- How much weight did people lose?
- People on the pill lost clearly more weight than those on the placebo at every dose over 72 weeks, and far more of them lost at least 5% of their body weight.
- What were the side effects?
- Mostly mild to moderate stomach symptoms. Nausea was the most common reason to stop, mainly at the highest dose.
- Who was in the trial?
- 238 Japanese adults with obesity-related health problems who had already tried dieting without lasting success.
